AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06776978 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Stimulation
Description: Participants receive sham tDCS using a battery-driven Eldith (neuroConn GmbH) Programmable Direct Current Stimulator with surface-soaked sponge electrodes (5×7 cm). No therapeutic current is applied during the 20-minute session. The electrode placement mimics the active condition, targeting the left frontal region (F5 of the extended International 10-20 EEG system), corresponding to Broca's area, while the reference electrode is placed over the contralateral frontopolar cortex. Sham tDCS is performed for 10 daily sessions over two consecutive weeks (5 days per week).
Study NCT05938452 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glyceryl Tribenzoate
Description: Oral Solution
Study NCT05938452 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Glyceryl Tribenzoate
Description: Oral Solution
Study NCT06090747 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Hybrid lifestyle educational multidisciplinary intervention.
Description: Participants will receive a standardized educational healthy lifestyle intervention. The information will be shared via digital tools such as mail, WhatsApp, zoom workshops, educational videos, Joven, Fuerte y Saludable webpage, Joven, Fuerte y Saludable mobile app, and face-to-face educational sessions.
Study NCT06090747 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Hybrid lifestyle personalized multidisciplinary intervention.
Description: Participants will receive a standardized educational healthy lifestyle intervention and personalized lifestyle intervention based on their clinical evaluation. Based on clinical records participants will be sent to nutritional, psychological, rehabilitation, and Mindfulness intervention. Educational and motivational strategies include digital tools such as mail, WhatsApp, zoom workshops, educational videos, the Joven, Fuerte y Saludable webpage, and the Joven, Fuerte y Saludable mobile app. And individualized follow-up through Mobile apps such as AVENA
Study NCT05012137 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB) with 0.5% ropivacaine
Description: all the patients received Ultrasound-guided Supra-anterior Superior Iliac Spine Fascia Iliaca Compartment Block (SASIS-FICB)
Study NCT05012137 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: different volume of 0.5% ropivacaine
Description: According to the subject's response to the injection dose, the next subject will be injected with a different volume of the drug according to the preset rules
Study NCT05237700 — intervention group
Intervention type: OTHER
Intervention: Patient positioning on operating table
Description: The patients are either positioned in Trendelenburg with lithotomy positioning or in Trendelenburg without lithotomy positioning on the operating table when undergoing robotic assisted laparoscopic surgery or laparoscopic surgery.
Study NCT05085054 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib Mesylate
Description: Participants will receive targeted therapy followed by salvage surgery
Study NCT06481696 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Resveratrol-based multivitamin supplement
Description: Natural polyphenol and vitamins
Study NCT06481696 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Folic acid
Description: Supplementation with folic acid at the standard dosage of 0.4 mg/die
Study NCT06481696 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IVF/ICSI
Description: In vitro fertilization/IntraCytoplasmic Sperm Injection
Study NCT06481696 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Follitropin Alfa
Description: Controlled Ovarian Stimulation
Study NCT06481696 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ganirelix Acetate 0.5 MG/ML [Fyremadel]
Description: GnRH Antagonist
Study NCT06481696 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: hCG 10.000 IU or triptorelin 0,3 mg, subcutaneously
Description: For the induction of oocyte maturation
Study NCT06775249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ICE Mindfulness Program
Description: The ICE Mindfulness Program is a tailored, self-paced intervention designed for crew members in isolated and confined environments. It includes a three-week pre-departure online course with videos, audio, and cognitive exercises promoting mindfulness, flexibility, and creativity, requiring 15-30 minutes daily. Delivered via email, it blends elements from Mindfulness-Based Stress Reduction and the Langerian approach. Participants receive new content daily, focusing on stress reduction and adaptation in extreme settings. Pre-departure, the PI leads a 1.5-hour interactive session with group meditation. During the mission, bi-weekly booster sessions are conducted by the ESA MD, supplemented by ongoing access to training materials. Exercises include meditations, mindful discussions, and cognitive tasks, with flexibility to fit participant schedules. The program will be available in Italian, French, and English.
Study NCT05116163 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Individuation Intervention plus implicit bias educational modules
Description: Providers in the intervention are will be instructed to watch a brief set of freely available educational lessons and then they will meet with study team members to discuss their individuation countermeasure intervention. Providers will be given a choice of several individuation-related questions to better understand the unique characteristics of each patient. Once the provider decides on his/her choice phrases, the research team will assist with the development of a smart phrase (also called dot phrase) to allow them to incorporate this into a note. Once a week, providers in the intervention arm will receive an email reminding them to incorporate this question and the documentation into their encounters.
Study NCT05116163 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Implicit bias educational modules
Description: Providers in the comparator arm will be given the same implicit bias educational modules to complete.
Study NCT05116163 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Implicit bias educational modules
Description: Providers in the comparator arm will be given the same implicit bias educational modules to complete.
Study NCT05657119 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MI FSN - Lethal Means Reduction
Description: Motivational Interviewing lethal means reduction, firearm storage supplies, Tailored text messages~* Participate in a 15-20-minute motivational interviewing (MI) session conducted by trained University of Michigan research staff focused on encouraging suicide lethal means~* Be offered to take home gun safety and lethal means reduction materials, including trigger locks, cable locks, ammo boxes, medication boxes and mental health resources~* Receive 4 weeks of tailored text message reminders and encouragement
Study NCT05657119 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Scripted FSN - Lethal Means Reduction
Description: Scripted lethal means reduction, firearm storage supplies, tailored text messages~* Participate in a 10-15-minute scripted session focused on gun safety and lethal means reduction~* Be offered to home gun safety and lethal means reduction materials, including trigger locks, cable locks, ammo boxes, medication boxes and mental health resources~* Receive 4 weeks of tailored text message reminders and encouragement
Study NCT05657119 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Firearm Safety Intervention - General Firearm Safety
Description: General information on gun safety, firearm storage supplies, tailored text messages~* Participate in a 10-minute scripted conversation about safe gun storage practice~* Be offered to take home safe gun storage materials, including trigger locks, cable locks, and ammo boxes~* Receive 4 weeks of tailored text message reminders and encouragement
Study NCT05657119 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: General Firearm Comparison - General Firearm Safety
Description: firearm storage supplies~\* Be offered to take home safe gun storage materials, including trigger locks, cable locks, and ammo boxes
Study NCT06526741 — intervention group
Intervention type: OTHER
Intervention: Longitudinal data collection
Description: This is an observational ambispective non-interventional registry collecting longitudinal real-world data only. There is no intervention.
Study NCT06775938 — intervention group
Intervention type: OTHER
Intervention: resident exam
Description: Resident exam in May 2024.
Study NCT05352763 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: simufilam
Description: simufilam 100 mg oral tablets
Study NCT04942106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Arm 1 - Side-lying position followed by Supine position
Description: Infants will be observed for two bottle feedings within a 24-hour period when they reach approximately 30-50% oral feeding. In this arm, infants will be bottle-fed in the side-lying position first followed by the supine position. In the side-lying feeding position, the infant will be placed on the caregiver's lap with one ear and hip facing the ceiling at a 45 to 60 degree angle. In the supine feeding position, the infant will be placed facing the caregiver in a reclining position at a 45 to 60 degree angle. In both feeding positions, the infant's head, neck, and upper body will be supported by the caregiver to maintain a neutral straight alignment with the chin tilted down slightly without the neck being extended or in excessive flexion. The infant will also be loosely swaddled with a single blanket so their legs, shoulders, and elbows are supported in a flexed position but with the lower arms free to move.
Study NCT04942106 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Arm 2 - Supine position followed by Side-lying position
Description: Infants will be observed for two bottle feedings within a 24-hour period when they reach approximately 30-50% oral feeding. In this arm, infants will be bottle-fed in the supine position first followed by the side-lying position. In the side-lying feeding position, the infant will be placed on the caregiver's lap with one ear and hip facing the ceiling at a 45 to 60 degree angle. In the supine feeding position, the infant will be placed facing the caregiver in a reclining position at a 45 to 60 degree angle. In both feeding positions, the infant's head, neck, and upper body will be supported by the caregiver to maintain a neutral straight alignment with the chin tilted down slightly without the neck being extended or in excessive flexion. The infant will also be loosely swaddled with a single blanket so their legs, shoulders, and elbows are supported in a flexed position but with the lower arms free to move.
Study NCT05917405 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fludarabine
Description: 30 mg/m2/day IV fludarabine for 5 days (day-6 to day-2)
Study NCT05917405 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Busulfan
Description: 130 mg/m2/day IV busulfan once daily for 2 days (day -4 and -3)
Study NCT05917405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Busulfan
Description: 130 mg/m2/day IV busulfan once daily for 2 days (day -4 and -3)
Study NCT05917405 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ATG
Description: Thymoglobuline®: 2.5 mg/Kg/day IV for 2 consecutive days (day -2 and -1)
Study NCT05917405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATG
Description: Thymoglobuline®: 2.5 mg/Kg/day IV for 2 consecutive days (day -2 and -1)
Study NCT06142656 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin Hydrochloride tablet
Description: Metformin Hydrochloride 850 mg oral tablet
Study NCT05917405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clofarabine
Description: 30 mg/m2/day IV clofarabine for 5 days (day-6 to day-2)
Study NCT06142656 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vildagliptin 50 MG
Description: Vildagliptin 50 MG oral tablets
Study NCT06016933 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: spirulina gel
Description: Patient were received spirulina gel in diseased sites. The process will be repeated at 7, 14, 21 days.
Study NCT06016933 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: SRP of all teeth
Description: Patients received oral hygiene instructions and SRP of all teeth.
Study NCT06016933 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: SRP of all teeth
Description: Patients received oral hygiene instructions and SRP of all teeth.
Study NCT05926908 — intervention group
Intervention type: BEHAVIORAL
Intervention: A Mobilisation Initiative
Description: The Mobilisation Initiative consists of physiotherapists assisting nursing staff in mobilising patients to sit in a chair for breakfast and lunch. This intervention follows the interventions of focus group interviews, formal education, observations of patients and the environment, and awareness of mobilisation survey
Study NCT05926908 — intervention group
Intervention type: BEHAVIORAL
Intervention: Focus Group Interviews
Description: Focus group interviews using a semi-structured interview guide are conducted with health care professionals at the wards to explore the acceptability and demand for the contents of the Mobilisation Initiative, including the identification of facilitators and barriers to mobilisation
Study NCT05926908 — intervention group
Intervention type: BEHAVIORAL
Intervention: Formal Education
Description: Formal education for all nursing staff employed at the two wards includes information on the consequences of immobilisation, with the purpose of enhancing confidence, competencies, and awareness of mobilisation
Study NCT05926908 — intervention group
Intervention type: BEHAVIORAL
Intervention: Self-reported Level of Mobilisation
Description: Patient's self-reported mealtime mobilisation level reported through interview-based surveys, including structured follow-up questions
Study NCT05926908 — intervention group
Intervention type: BEHAVIORAL
Intervention: Observations of Patients and the Environment
Description: During breakfast and lunch, the mobilisation status of all patients in the wards is observed using an observation checklist
Study NCT05926908 — intervention group
Intervention type: BEHAVIORAL
Intervention: Awareness of Mobilisation Survey
Description: To assess the nursing staff's awareness of and confidence in the mobilisation of the patients, a short survey on mobilisation awareness is distributed to the nursing staff at both wards
Study NCT06504108 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Calcium silicate-based sealer full Pulpotomy
Description: Using calcium silicate-based sealer as a capping agent after full pulpotomy
Study NCT06504108 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Calcium silicate-based premixed putty full Pulpotomy
Description: Using calcium silicate-based premixed putty as a capping agent after full pulpotomy
Study NCT06504108 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Full Pulpotomy
Description: Using combination between calcium silicate-based sealer and calcium silicate-based premixed putty as a capping agent after full pulpotomy
Study NCT06180564 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intra-operative Infra-red thermography
Description: . In the test group after devascularisation of the bowel segment surgeon marked the resection line using their conventional method, then IRT was used to determine the resection line using infra- red camera in rainbow display mode. Resection line was determined by abrupt colour change (corresponds to decrease in temperature >3 degree Celsius) over the visualised bowel wall. Margins were revised if difference between surgeon and IRT determined resection lines were more than 1cm apart.
Study NCT05820724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PSMA PET scan
Description: Subjects will undergo DCFPyL PET/CT imaging and mpMRI imaging prior to the prostate biopsy. The decision for biopsy targets will be made based on the combination of the findings of mpMRI and PSMA scans. The intervention includes a mpMRI, a PSMA PET scan, and a prostate biopsy.
Study NCT06045585 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: infusion of JY231 injection
Description: Infusion of JY231 Injection by dose of 1-10 x10\^6 TU/kg、 1-5 x10\^7 TU/kg、 5-10 x10\^7 TU/kg Administration method: intravenous infusion、intraperitoneally infusion、Lymph node infusion； Subjects will be treated with Fludarabine and Cyclophosphamide before cell infusion（PI evaluation is required）.
Study NCT05820724 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No PSMA PET
Description: Subjects will undergo mpMRI imaging prior to the prostate biopsy. These subjects do not undergo a PSMA PET scan prior to the prostate biopsy. The decision for biopsy targets will be made based on the findings of mpMRI. The intervention includes a mpMRI and a prostate biopsy.
Study NCT05820724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F- DCFPyl Injection
Description: DCFPyL is a PSMA imaging ligand that was developed to enhance the detection of small lesions in the prostate or other pelvic areas. 18F- DCFPyl Injection will be administered prior to the PSMA PET/CT via an in-dwelling catheter placed in an antecubital vein or an equivalent venous access under the direct supervision of study personnel.
Study NCT06373094 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil Dihydroxynaphthalate for Injection
Description: HHT201 will be injected into the muscle of gluteus.
Study NCT05555589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGN-259
Description: A preservative-free, sterile eye drop solution containing Tβ4 for direct instillation into study eye(s), five times per day for 28 days
Study NCT05616533 — intervention group
Intervention type: OTHER
Intervention: biopsy of tumor before treatment
Description: samples obtained from biopsy will be used in the zebrafish PDX model
Study NCT05555589 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: It is composed of the same excipients as RGN-259 but does not contain Tβ4. Direct instillation into study eye(s), five times per day for 28 days
Study NCT04759820 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: injecting Carbon Nanoparticles Suspension
Description: injecting Carbon Nanoparticles Suspension for lymph node detection
Study NCT06483672 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: Furmonertinib 80mg, once daily, orally
Study NCT06483672 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib
Description: Anlotinib 12mg, once daily (days 1-14, 21 days per cycle), orally
Study NCT04759820 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Injecting indocyanine green
Description: Injecting indocyanine green for lymph node detection
Study NCT06543225 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT04211714 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: EXG34217
Description: Single infusion
Study NCT04851613 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib
Description: The starting doses of the combination therapy are afuresertib 125 mg PO, QD plus fulvestrant 500 mg IM, D1, 15 in the first cycle and afuresertib 125 mg PO, QD plus fulvestrant 500 mg IM, D1 Q4W in the subsequent cycles
Study NCT04851613 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib/placebo
Description: afuresertib/placebo 125mg QD combined with fulvestrant 500mg Q4W (D1, 15 in cycle 1)
Study NCT04851613 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Afuresertib/placebo
Description: afuresertib/placebo 125mg QD combined with fulvestrant 500mg Q4W (D1, 15 in cycle 1)
Study NCT06581419 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IAP0971
Description: Subjects receive IAP0971, which will be administered every 3 weeks in a 3-week cycle.
Study NCT06170008 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Physical microstructure-modified transparent silicone film sheet
Description: The main component of the physical microstructure-modified transparent silicone film sheet is transparent silicone rubber, which has a three-dimensional microstructure on its trauma contact surface through physical mechanics treatment, which can provide effective mechanical stimulation for trauma healing. And after testing, the silicone film sheet is breathable, light-permeable, non-toxic and non-allergenic. It is expected to significantly reduce the number of dressing changes, reduce the damage to the wound and the painful stimulation to the patient during dressing changes, and promote the healing of the wound to a certain extent, thus improving the quality of wound repair and saving medical costs.
Study NCT06170008 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Decellularized pig skin
Description: Decellularized pig skin is an allogeneic trauma covering from pigs and is a commonly used trauma covering for second-degree burn wounds. It adheres to clean superficial wounds, creates a temporary barrier to the wound, reduces wound exudation, limits loss of body components, improves microcirculatory stasis, provides a microenvironment suitable for wound healing, protects inter-ecological tissue, promotes repair and regeneration, and reduces pain. Its disadvantages are: soft structure, difficult to fix the trauma; opaque, unable to observe the trauma; pigskin needs to be stored under suitable temperature and humidity, and has a limited time. When used, decellularized pig skin is directly covered on conventionally treated second-degree burn wounds.